NextCure, Inc. announced the publication of a paper titled “Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-ß signaling enables PD-L1-mediated tumor eradication” in the Journal of Clinical Investigation. This publication outlines data from a preclinical study on the impact of collagens in the extracellular matrix (ECM) on tumor immune infiltration, immune cell activation and anti-tumor responses. The study investigated the effect of targeting collagens in the tumor microenvironment (TME) that signal through the inhibitory leukocyte-associated immunoglobin-like receptor-1 (LAIR-1) in combination with targeting TGF-ß and programmed cell death ligand 1 (PD-L1) in murine models of cancer.